According to Nima Tamaddoni, Co-Founder and Chief Executive Officer of the Knoxville-based company, the new product is “the world’s best nanomedicine manufacturing platform,” citing factors such as lowest cost, high quality, high throughput, reliable and fully customizable in hardware and software for scale, compliance, and quality control.
He adds that the features that set it apart from any competitor include hardware customization for scaled and specific drug products, flow and pressure sensing for real-time flow rate and pressure measurement, software with connectivity for live customer support, and cloud or non-connective stand-alone software in pharma manufacturing spaces.
“It was a true honor and pleasure to push the NanoSizer FLOW GMP to the finish line and launch it,” Tamaddoni told us in a recent email. “We started this platform to help millions of people reaching life-saving gene therapeutics and vaccines the fastest with the lowest cost possible. (For) either a small company or a large pharmaceutical manufacturer or formulation company, this platform provides a reliable, low-cost, high quality, high throughput solution in a very high range (100mL-500L+) for the cGMP manufacturing of therapeutics and vaccines.”
He also expressed a “big thanks to our team and everyone involved in (the development of) this technology.”
For the scientifically inclined readers, Alex Aust, T & T Scientific’s recently named Director of Business Development, explains the NanoSizer FLOW GMP is explained in this short YouTube video.
The life science company was founded in 2015 by two then University of Tennessee, Knoxville graduate students – Tamaddoni and Graham Taylor. The latter serves as President and Chief Operating Officer.